BiotechTube
Home/NovalGen/Dr. David Granger
DD

Dr. David Granger

VP R&D

NovalGen

Therapeutic Areas

OncologyAutoimmuneHaematologicalMetabolic

NovalGen Pipeline

DrugIndicationPhase
NVG-222Not Specified (Oncology/Haematological)Phase 1
Lead Self-Regulating ImmunotherapyNot SpecifiedPre-clinical/Phase 1

Leadership Team at NovalGen

BT
Bharat Thakrar
Chairman
PA
Professor Amit Nathwani
Chief Executive Officer
View full NovalGen profile